0001104659-20-083297.txt : 20200714 0001104659-20-083297.hdr.sgml : 20200714 20200714103034 ACCESSION NUMBER: 0001104659-20-083297 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200708 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200714 DATE AS OF CHANGE: 20200714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOVELION THERAPEUTICS INC. CENTRAL INDEX KEY: 0000827809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-17082 FILM NUMBER: 201026538 BUSINESS ADDRESS: STREET 1: C/O NORTON ROSE FULBRIGHT STREET 2: 1800 - 510 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6B 0M3 BUSINESS PHONE: (877) 764-3131 MAIL ADDRESS: STREET 1: C/O NORTON ROSE FULBRIGHT STREET 2: 1800 - 510 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6B 0M3 FORMER COMPANY: FORMER CONFORMED NAME: QLT INC/BC DATE OF NAME CHANGE: 20000608 FORMER COMPANY: FORMER CONFORMED NAME: QLT PHOTO THERAPEUTICS INC DATE OF NAME CHANGE: 19960618 FORMER COMPANY: FORMER CONFORMED NAME: QUADRA LOGIC TECHNOLOGIES INC DATE OF NAME CHANGE: 19941201 8-K 1 tm2024731d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 8, 2020

Novelion Therapeutics Inc.

(Exact Name of Registrant as specified in its charter)

British Columbia, Canada		000-17082		98-0455702
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

c/o Alvarez & Marsal Canada Inc.

Commerce Place 400 Burrard Street, Suite 1680, Vancouver, BC V6C 3A6 Canada

(Address of principal executive offices)

Registrant’s telephone number, including area code: 604-638-7440

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares, without par value	NVLNF	OTC Markets

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01. Other Events.

On July 8, 2020, Novelion Therapeutics Inc. issued a press release announcing that it has ceased to be a reporting issuer under Canadian securities legislation, which press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press Release, dated July 8, 2020.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Novelion Therapeutics Inc.


	By:	/s/ Alvarez & Marsal Canada Inc.
	Name:	Alvarez & Marsal Canada Inc.
	Title:	Liquidator, acting solely in such capacity and not in its personal capacity

Date: July 13, 2020

3

EX-99.1 2 tm2024731d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Novelion Therapeutics Ceases to be a Reporting Issuer in Canada

VANCOUVER, British Columbia, July 8, 2020 – Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “Liquidator”) announces that it has ceased to be a reporting issuer under Canadian securities legislation in each of the provinces of Canada as a result of an order issued by the British Columbia Securities Commission on behalf of itself and other Canadian securities regulatory authorities. The order was issued in response to an application made by Novelion and accordingly, Novelion will no longer be required to file financial statements or other continuous disclosure documents with Canadian securities regulatory authorities.

A copy of the order is available on the website established by the Liquidator at www.alvarezandmarsal.com/novelion.

The Liquidator, on behalf of Novelion, intends to issue news releases or provide other material updates related to the status of the liquidation, including on current reports on Form 8-K to be filed with the U.S. Securities and Exchange Commission (the “Commission”), on an as needed basis to keep shareholders apprised of the progress of the liquidation. Novelion does not intend to file any financial statements or any periodic or other reports or filings with the Commission, except for the aforementioned current reports. Shareholders are encouraged to check www.alvarezandmarsal.com/novelion from time to time for updates.

As noted in Novelion’s June 12, 2020 press release, the Liquidator continues to believe that Novelion will be able to complete distributions in the fourth quarter of 2020, subject to the resolution of claims and other ongoing administrative matters including the finalization of tax returns and related matters in Canada and the U.S.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” and “forward-looking information” within the meaning of applicable laws and regulations, including U.S. and Canadian securities laws. Any statements contained herein which do not describe historical facts, including, but not limited to, the Liquidator’s intention to issue news releases or provide other material updates related to the status of the liquidation, the Liquidator’s actions with respect to the liquidation, the amount, timing and nature of any distribution as part of the liquidation and the ultimate outcome of the liquidation process are forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements.

1

Such risks and uncertainties include, among others, the impact of any determinations of the Supreme Court of British Columbia and the actions of the Liquidator undertaken as part of the liquidation, the possibility that there could be claims or actions that result from the claims process conducted as part of the liquidation or otherwise, the possibility that such claims and actions could be costly to defend and could have negative outcomes, the possibility that actual expenses and claims that result from the liquidation will be greater than anticipated, and the potential impact of any volatility in the market price of the ordinary shares of Amryt Pharma plc currently held by the Company, any or all of which could materially reduce the availability of assets available for distribution to shareholders, as well as those risks identified in Novelion’s filings with the Securities and Exchange Commission (the “SEC”) and Canadian securities regulators, including the definitive proxy statement filed on October 3, 2019, which are available on the SEC’s website at www.sec.gov and on SEDAR at www.sedar.com. The impact from any such risks and uncertainties could materially reduce or eliminate the availability of assets available for distribution to shareholders.

Novelion cautions investors and others not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. Except as required by law, Novelion undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

CONTACT:

Nishant Virmani

Alvarez & Marsal Canada Inc.

nvirmani@alvarezandmarsal.com

www.alvarezandmarsal.com/novelion

2

EX-101.SCH 3 nvln-20200708.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 nvln-20200708_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 nvln-20200708_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2024731d1_ex99-1img001.jpg GRAPHIC begin 644 tm2024731d1_ex99-1img001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# (! 0(! 0(" @(" @(" P4# P,# M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_ MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P, M# P,# P,# P,# P,# P,# P,# P,# S_P 1" X +<# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]_***I:[K MD/AZP^T3[BNX* HR230!+?:K;:84^T3QP^8=J;VQN-9=[X6GNO%L.HB[*Q1@ M9CYSP.@[8/>EOM$L?'5I:W3&;8!E<':2.X/Y5-/XLM+/7H]-/F>:V "%^4$C M@4 7+;5K:\NI((IXY)8?OHK9*U9K(L_#5EX?F.<8'%=U\>?VM/!G[-^J: M59^)[NZAGU?G5J*/L7%3;T2YU> M.K[GT4>%,TG2PU6C2<_K"FX*.K:@[2T6JM^1Z71389EN(5="&1P&4CH0>E.K MVCYT**** "BBB@"#4KMK'3YIEC,K1(6"#JV.U9GA[41XTT1S>VBA=^W:PRK8 MYR,TWPN^L-J-W_:( @S^[Z=<_P ..V/6K/BO[>-'/]FC]_N&<8SM[XSQF@"I MXF\0R>$Q9PVMEYD;_+A00% Q\HQWK5;2[::]2Z:"/[0HP'*_,M)HIN3I4'VS M'VG8/,QZUFW?]L?\)A%Y>/[-P-W3&,6IQS4GC7^U3X.U7^P_(_MK['+]@\__5>? ML/E[O;=C->5_L5)\4X_ NJ?\+3)-_P#;3]A\TQ&?RL?-N\OY=N?N]_O=L5P5 MZK=)/HWT/4H99[7 U<=[6"]FXKD;]^7-UBNJ77L>M>' M]2DU?2(;B6+R'D&2GX]?QJ[6+XR75FA@_LLX.\^9C&?;KV]:V(=WDKOQOP-V M.F>]=YY9\M?$/_@IU8^ /C!XG\(?\(AJ>I7>D2&UT\VLX9[^X5@K*R[.2-3LSU;L,G! MQ7)_LY6<5U_P57\<-)&DC0-J,D99KVLK'O7[6?[;.A_LMBSL M&LIM=\2:DGF6VG02!-J9(#R-@E02" "3@],9KR?2O\ @J/JWA7Q!8Q>/_AI MK'AC2]0($=U^]W@9&6"21KO SS@Y_E7*^,(H]2_X*Y:(FL*CVL?VZ6M8\C!9'D&$JY9E.+PCK3QD(2E4Y MY)Q]HVDHI>[[O6Z=S4\8_MTZ3X1_:+\+>"VTYI=(\4VL%Q;:V)\12?:.(2BX MPR$X!;<,$GCCGNOVE_CW9?LV_"+4/%%Y!]L:W9(;:U$GEFYF,XDD&M>#8Y,NG^L:Q:X=5.>OR8C(]%+&J?QF^- M%U^WUXF^$?@;2Y\R3P1W.MM&/EANCE9FY'_+..-W'8B0BL*G&6/HTJU.I_%J MQISH*R_Y>I+E\^27>]^IT4?#S+,17PU:C_ H3JT\4[O_ )UDNFI M]%>,O^"B>A^ O@#X9\6ZAH]V-9\5PO)9Z*DHWG8Y1G:3'$9(!!VY(88'!QPF MG_\ !4C6_"VL:>WCCX8ZMXIQ76?&[X2?M+_'GP'+H'B3 M3_#!X4X7IX;#5L5"DH8E.;=2O*$X0E)\JIQVER+=R>K3*O_!4;7;3Q M1\0?A%J6GW$=W8W]O-<6\T9RLL;O RL/8@BO5/V_OB!X%\&>+_ 5OXM\#1>+ MI]0N)!#*]TT'V2)6C#\+_K,EP0C?+\I]:^??VS_A_J/PKT3X#>'M6>*34=+L M9X9_*;L,;CJT(9KB902FWAF MU)*23:C=6DFM#IRW+NVQ[;^UC^VY MH?[+3V6E)82Z[XDU",26^FP/Y8C0DJK.V"0"00 %).T].M>7:-_P5&U3PMXD ML8/B#\-]7\*Z;J!'EW7[W>HXRPCDC7>!D9VG/L3@5RVM1P:C_P %A($UOF&& M2,V2R_=WC3PT6/\ MI@C_:QWKUG_ (*JVEC-^R9>272PFZAU&V-DSXW"0L0V MWW\OS/P'M7MXK-Z6M8^>2<74;2Y4O=]SK=._4W/VJ?VX]+_9J@\(W"Z:VO67BG=.M MQ#$9) L&I7_G^1T/(.'LHIY?0Q>$]O.O5JTY27DUX98ILD*<^N8<*RME__P!:KM%% '@?PM_8XO/A]^V!XG^),NLVUQ8ZS'/Y%HL3"9&F96;< M>@"X(&,YR.F.7?ML_L=WG[5LWA5K/6+;2O["FF\_SHR^^.3R\E'Y$O->A.KZP8KI8=9NHT=#;3OM"B0!1N13A0.E07GB[3/A M1\7+32[[69;/2CH3R0I>WDDWF2_:1EMSDL6 .,D\ XZ5X,N&K;4M[WW1]1#C/-89A1S2-1>UI14(OE6D5%Q2M:ST;U9Q?[7?["]M^T7 MJ&F:]H^KMX>\6:/&D45X%.V=4.Y-Q4AE93DAQG&>AP,>9WG_ 3V^)_QHU?3 MHOB=\2$U'1-,DWI!:RR3NXZ$@.B*&(XWD,>O!KVKQS\6;;Q!K/B,Z%KWG6]C MX1NKA_LTY @E\P;9..C X/48K>\'1^$KV66?P_K]WJ5_8VS2[!KMQ=A05(W M,C2,IY/<=:Y,=P9E>+KRQ%6+]^W,E*2C*VW-%.S._+/$3.\#A886A.-H74)2 MA&4H)[\DFFU_5CJK?X=:-:_#Q?"B6,0T%;#^S!:=5^S[/+V?]\]Z\)_8U_8$ MC_9>^(.O:]>:G;:O/=(;732D95K>$MN9GST=L*,#@?-R=W&QI.M:98_!W1M5 MTGQ/?7?C*>PM)8;8:W+>-?73JI,3P-(R[7;(;Y1M&3E<9'>?%^]U?6+ZST30 M+F6VU*&%]8E:)MN]82/*@8]-LLNU2.Z+)7J8C),%7Q%'%5(+GHWY/*^FVWIV MZ'AX3B3,<-A,1@J-5J&(MSK>]G??=7ZVW6C./_;#_8QT_P#:FT_3[N+4'T3Q M)HV19WRIO5D)W;' (. >008X-?1/C_P 46?B[0_ ]T;^XT_2=;U!6G:.]:T)4VD[B-I$9 M2,.JY&>JUS7CS6;3PQ9Z[:Z%XDU"?2TTGS[]O[3DN1ITGVB)499RS-&SQM-E M0W2,, .I\S,>#LLQN(EB:T6I2^+EE**E;^9)JY[64^(.-8-0UGPA+/\ ;[V>)W-S%)*CJ%;JS(J! M!?%.H>&-?O;V_P!-TBZ?B2S+,K8=7$!(8'USSFJQ7"&5UYU*DX/]XHJ24I) M-1:<=$[77*E?>WJR,%Q]G6%ITJ5.JOW4I2BW&+:3_M? M_L-1?M&:]I_B71-8?PWXMTM%CCNE#;)U4[DR5(9'4DX<9..W QYI0Q]C7N_P 3/",+1>&+Y;[7 M89]7U>S@NO)U>ZC21'0[E"+(%4' Z 58\8ZM+\)M6V:=)=SPVOA^^NHH+N[E MG66X\^V6,NSL6(R^.O )Q48W@S*\77EB*L'>;3DE*2C)K;FBG9FN6^(F=X'" MPPM"<;4TU"3A&4X)[J,FFU_5CA/VKOV&/^%[VO@6TT'4;/0=/\'JUJ+=XF8" MW/E ;,?Q*(\8/7/48Y]=^-OPX;XL_"#Q!X8BN5LY-9L7M8YV34JYZ)LVXZ@UA>,H[:P\8N/&=U MJ[:)'90+97DKU27* MDNVG:QXM3B7,*E/#4YSNL.W*&BNG*7,VWU]Y7UN)^Q]^S_=?LU?!:W\-7M_! MJ-VMS+) MB"JF1?\ 6 =F.6(ZD]:*[,#@J6$P\,+05H022ZZ(\_,LQKX_%U,;B7>=1N3> MVK\D==11174<16OM)MM3:,W$$+X].%H3$P&9.<],Y] M,#I110!IVNDVUE]%% &+ M\3_ 6J>)=;U>>SA22.Z\,W.FQ9D"[IW<,J\] 0.O2M>W\0:MJL1LY/"^I6*S M1-&9Y+FV9(SM.,[)"W7C@=Z** .?TOX8W_A7P3X5O],M+6/Q1X>TV"SN8%*J MNH1!$$UNS].J[D8\!P.S-F[I_P )D\2^)=:UK7EOHKR]N!!;);:G/"L5I$-L M0(B=1EB9)#UQYF.U%% &9I?PBO-%U'3M,CMH[CP]I.OOJ-IY\HE*6\MK/O0A MB68K<2'!.3AQ_=-=/\3?"LFH_#?4K#2+*(SR!'C@CVQ"1E=6(R<*"0O>BB@" M#5I]2\?:'J6B7&@:CI$.JV4]J;R6:VD6'?&R@E4D+'KZ5DZC/XEUKX;/X=/A MN:#4KJS.G37+W4)LHE9?+:8,&WL,98+LW'@''6BB@#:\?>$;K5[3PU#9*)%T MK5K6YE+N%(BC# GW/(XJM\0/AU/XY\2."WD65QH5WI[7"D%X99)(&1@O?'ED M_P# 1ZT44 20^,O$UKI'DS^%)[G5T&S=!>0K93L.-X=FWJAZX*%ATP>]AO$? MB+1M0:.]T(:E;/$C13Z9,F4?: \;I*RG&[<58$Y4C(!')10 GPI\-W/A[2=1 D:YLH=+_M+4);V*PB<.MFC!1MROR[F*L[;>-TAP3U)110!__9 end XML 7 tm2024731d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000827809 2020-07-08 2020-07-08 iso4217:USD shares iso4217:USD shares 0000827809 false 8-K 2020-07-08 Novelion Therapeutics Inc. A1 000-17082 98-0455702 c/o Alvarez & Marsal Canada Inc. Commerce Place 400 Burrard Street, Suite 1680 Vancouver BC V6C 3A6 CA 604 638-7440 false false false false Common Shares, without par value NVLNF false XML 8 R1.htm IDEA: XBRL DOCUMENT

Cover	Jul. 08, 2020
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jul. 08, 2020
Entity File Number	000-17082
Entity Registrant Name	Novelion Therapeutics Inc.
Entity Central Index Key	0000827809
Entity Tax Identification Number	98-0455702
Entity Incorporation, State or Country Code	A1
Entity Address, Address Line One	c/o Alvarez & Marsal Canada Inc.
Entity Address, Address Line Two	Commerce Place 400 Burrard Street, Suite 1680
Entity Address, City or Town	Vancouver
Entity Address, Country	CA
Entity Address, Postal Zip Code	BC V6C 3A6
City Area Code	604
Local Phone Number	638-7440
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Shares, without par value
Trading Symbol	NVLNF
Entity Emerging Growth Company	false

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://novelion.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2024731d1_8k.htm nvln-20200708.xsd nvln-20200708_lab.xml nvln-20200708_pre.xml tm2024731d1_ex99-1.htm http://xbrl.sec.gov/dei/2019-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2024731d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2024731d1_8k.htm" ] }, "labelLink": { "local": [ "nvln-20200708_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nvln-20200708_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nvln-20200708.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nvln", "nsuri": "http://novelion.com/20200708", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2024731d1_8k.htm", "contextRef": "From2020-07-08to2020-07-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://novelion.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2024731d1_8k.htm", "contextRef": "From2020-07-08to2020-07-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r9" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://novelion.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r11": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r12": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r13": { "Name": "Forms 10-K, 20-F, 40-F", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-1" }, "r14": { "Name": "Forms 20-F, 40-F", "Number": "249", "Publisher": "SEC", "Section": "220 and 240", "Subsection": "f" }, "r15": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r18": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" } }, "version": "2.1" } ZIP 15 0001104659-20-083297-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-083297-xbrl.zip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end